Search

everythinglearnresearchcommunity

for

Search:↓

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Left-handed men experience more sexual side effects from finasteride treatment.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

PCOS has a strong genetic basis, but more research is needed to fully understand it.